MONTELEONE, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 73.486
EU - Europa 4.817
AS - Asia 1.316
SA - Sud America 29
Continente sconosciuto - Info sul continente non disponibili 21
AF - Africa 12
OC - Oceania 11
Totale 79.692
Nazione #
US - Stati Uniti d'America 73.451
UA - Ucraina 931
CN - Cina 912
DE - Germania 808
IE - Irlanda 802
IT - Italia 630
GB - Regno Unito 353
SE - Svezia 310
FR - Francia 285
KR - Corea 266
PL - Polonia 229
FI - Finlandia 215
RU - Federazione Russa 97
BE - Belgio 55
JP - Giappone 28
NL - Olanda 24
IN - India 21
CA - Canada 20
BR - Brasile 18
HK - Hong Kong 17
RO - Romania 16
EU - Europa 13
CH - Svizzera 11
MX - Messico 10
AU - Australia 9
CL - Cile 9
IL - Israele 9
KG - Kirghizistan 9
BD - Bangladesh 8
IR - Iran 8
VN - Vietnam 8
AT - Austria 7
GR - Grecia 7
SC - Seychelles 7
ES - Italia 6
TR - Turchia 6
DM - Dominica 5
NO - Norvegia 5
SG - Singapore 5
A1 - Anonimo 4
CZ - Repubblica Ceca 4
HU - Ungheria 4
PH - Filippine 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
DK - Danimarca 3
EE - Estonia 3
LK - Sri Lanka 3
EG - Egitto 2
KW - Kuwait 2
KZ - Kazakistan 2
LT - Lituania 2
MK - Macedonia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
AR - Argentina 1
BJ - Benin 1
BT - Bhutan 1
LB - Libano 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 79.692
Città #
Woodbridge 21.946
Wilmington 19.214
Houston 18.456
Fairfield 2.611
Ann Arbor 2.043
Chandler 1.316
Ashburn 1.207
Seattle 1.050
Cambridge 877
Jacksonville 837
Dublin 722
Medford 578
Dearborn 471
Beijing 417
Rome 278
Lawrence 267
Kraków 221
New York 187
Zhengzhou 157
San Diego 144
Menlo Park 119
Mülheim 95
London 64
Milan 57
Mountain View 56
Redwood City 55
Boardman 54
Brussels 54
Norwalk 43
San Mateo 41
Seoul 40
Shanghai 35
University Park 35
Verona 33
Hangzhou 32
Falls Church 31
Palo Alto 31
Hefei 29
Chicago 25
Kunming 25
Colorado Springs 24
Helsinki 23
Nanjing 22
Guangzhou 21
Saint Petersburg 19
Detroit 17
Jinan 17
Del Norte 16
Redmond 15
Council Bluffs 14
San Francisco 14
Kilburn 13
Nürnberg 13
Saint Louis 13
Wuhan 13
Nanchang 12
North Hollywood 11
Toronto 11
Changsha 10
Durham 10
Chengdu 9
Hounslow 9
Indiana 9
São Paulo 9
Hanover 8
Hong Kong 8
Mcallen 8
San Jose 8
Shenyang 8
Fuzhou 7
Hebei 7
Mahé 7
Mexico City 7
Prescot 7
Tokyo 7
Auburn Hills 6
Engelhard 6
Los Angeles 6
Napoli 6
Phoenix 6
Tappahannock 6
Warsaw 6
Amsterdam 5
Baotou 5
Bari 5
Cedarhurst 5
Groningen 5
Lappeenranta 5
Mentana 5
Orlando 5
Pune 5
Quzhou 5
Roseau 5
Washington 5
Brisbane 4
Buffalo 4
Darlington 4
Dhaka 4
Dong Ket 4
Duncan 4
Totale 74.505
Nome #
A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction 474
2-Methoxy-5-Amino-N-Hydroxybenzamide Sensitizes Colon Cancer Cells to TRAIL-Induced Apoptosis by Regulating Death Receptor 5 and Survivin Expression 462
Regulation of the T helper cell type 1 transcription factor T-bet in coeliac disease mucosa 458
Appropriate nutrient supplementation in celiac disease 456
2-Methoxy-5-amino-N-hydroxybenzamide, a derivative of mesalamine, inhibits colon cancer cell growth through cyclo-oxygenase-2-dependent and -independent mechanisms 453
A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis 447
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 440
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 438
Inhibiting Oxidative Phosphorylation In Vivo Restrains Th17 Effector Responses and Ameliorates Murine Colitis 437
Interleukin-34 sustains inflammatory pathways in the gut 431
Frequency and cause of persistent symptoms in celiac disease patients on a long-term gluten-free diet 430
Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation 429
A functional role for Smad7 in sustaining colon cancer cell growth and survival 428
Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract 427
5-aminosalicylic acid enhances anchorage-independent colorectal cancer cell death 426
No change in the mucosal gut microbiome is associated with celiac disease-specific microbiome alteration in adult patients 426
Smad7 induces plasticity in tumor-infiltrating Th17 cells and enables TNF-alpha-mediated killing of colorectal cancer cells 422
TNF-α producing innate lymphoid cells (ILCs) are increased in active celiac disease and contribute to promote intestinal atrophy in mice 422
High expression of the "A Disintegrin And Metalloprotease" 19 (ADAM19), a sheddase for TNF-α in the mucosa of patients with inflammatory bowel diseases 420
High Smad7 sustains inflammatory cytokine response in refractory coeliac disease 419
Interleukin-25 Inhibits Interleukin-12 Production and Th1 Cell-Driven Inflammation in the Gut 418
Regulation of gut inflammation and Th17 cell response by interleukin-21 417
Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection 417
Role of interleukin-21 in inflammation and allergy 416
Bacteria and mucosal immunity 416
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid 415
IL-21 comes of age as a regulator of effector T cells in the gut 415
The dual role of Smad7 in the control of cancer growth and metastasis 414
Breast milk lactoferrin regulates gene expression by binding bacterial DNA CpG motifs but not genomic DNA promoters in model intestinal cells 413
Targeting interleukin-21 in immune-mediated pathologies 413
Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease 411
Common immunologic mechanisms in inflammatory bowel disease and spondylarthropathies 411
Characterization of IL-17A-producing cells in celiac disease mucosa 411
Immunity, inflammation, and allergy in the gut 410
The gut-skin axis in health and disease: A paradigm with therapeutic implications 408
Lactobacillus paracasei subsp paracasei B21060 suppresses human T-cell proliferation 407
Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy 407
Tofacitinib for the treatment of ulcerative colitis 407
Silencing of SH-PTP2 defines a crucial role in the inactivation of epidermal growth factor receptor by 5-aminosalicylic acid in colon cancer cells 406
Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth 406
Smad7 Expression in T cells Prevents Colitis-Associated Cancer 405
Mongersen, an oral Smad7 antisense oligonucleotide, in patients with active Crohn's disease 404
Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease 403
Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection 402
Extracellular signal-regulated protein kinase mediates interleukin 17 (IL-17)-induced IL-8 secretion in Helicobacter pylori-infected human gastric epithelial cells 402
Aryl hydrocarbon receptor and colitis 402
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 402
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 402
Interleukin-21 (IL-21) controls inflammatory pathways in the gut 401
Autocrine regulation of IL-21 production in human T lymphocytes 401
Colorectal cancer chemoprevention by mesalazine and its derivatives 401
Inhibition of colon carcinogenesis by 2-methoxy-5-amino-N-hydroxybenzamide, a novel derivative of mesalamine 400
The Dual Role of Interleukin-25 in the Control of Immune-Mediated Pathologies 400
Local immune activity in acute coronary syndrome: oxLDL abrogates LPS-tolerance in mononuclear cells isolated from culprit lesion 398
Pyoderma gangrenosum in refractory celiac disease: a case report 397
Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21 397
Inhibition of monocyte-derived inflammatory cytokines by IL-25 occurs via p38 Map kinase-dependent induction of Socs-3 396
Compartmentalised expression of meprin in small intestinal mucosa: enhanced expression in lamina propria in coeliac disease 395
Molecular Targets of TRAIL-Sensitizing Agents in Colorectal Cancer 395
Helicobacter pylori infection associates with a mucosal downregulation of Ghrelin, negative regulator of Th1-cell responses 395
Protease-activated receptor-2 activation in gastric cancer cells promotes epidermal growth factor receptor trans-activation and proliferation 394
Erratum: A Role for Timp3 in Microbiota-Driven Hepatic Steatosis and Metabolic Dysfunction (Cell Reports (2016) 16(3) (731–743) (S2211124716307677) (10.1016/j.celrep.2016.06.027)) 394
Interleukin-12 drives the Th1 signaling pathway in Helicobacter pylori-infected human gastric mucosa 393
Activated STAT4 and a functional role for IL-12 in human Peyer's patches 393
Distinct profiles of effector cytokines mark the different phases of Crohn's disease 393
Smad7 knockdown restores aryl hydrocarbon receptor-mediated protective signals in the gut 393
Peritoneal expression of matrilysin helps identify early post-operative recurrence of colorectal cancer 393
Role of Smad7 in inflammatory bowel diseases 391
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 390
IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting Tregs in adipose tissue and systemic insulin sensitivity 390
An overview of the role of innate lymphoid cells in gut infections and inflammation 389
IL-21 counteracts the regulatory T cell-mediated suppression of human CD4+ T lymphocytes 388
Interleukin-34 induces Cc-chemokine ligand 20 in gut epithelial cells 387
Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies 386
New players in the cytokine orchestra of inflammatory bowel disease 384
Collagen matrix injection combined with flap repair for complex anal fistula 384
Sampling of proximal and distal duodenal biopsies in the diagnosis and monitoring of celiac disease 384
Celiac disease-related inflammation is marked by reduction of Nkp44/Nkp46-double positive natural killer cells 384
The dual role of inflammation in colon carcinogenesis 383
Targets for new immunomodulation strategies in inflammatory bowel disease 383
Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer 383
A functional role for interleukin-21 in promoting the synthesis of the T-cell chemoattractant, MIP-3 alpha, by gut epithelial cells 382
Overview of role of the immune system in the pathogenesis of inflammatory bowel disease 382
Transforming growth factor beta signalling and matrix metalloproteinases in the mucosa overlying Crohn's disease strictures 382
Emerging immunological targets in inflammatory bowel disease 382
Analysis of the cytokine profile in the duodenal mucosa of refractory coeliac disease patients 381
T-cell-directed therapies in inflammatory bowel diseases 380
Interleukin-21 in Immune and Allergic Diseases 380
Impact of patient characteristics on the clinical efficacy of mongersen (GED-0301), an oral Smad7 antisense oligonucleotide, in active Crohn's disease 380
Inhibition of colitis by IL-25 associates with induction of alternatively activated macrophages 379
IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa 378
TGF-beta 1 and Smad7 in the regulation of IBD 378
The aryl hydrocarbon receptor in inflammatory bowel disease: linking the environment to disease pathogenesis 378
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer 378
Inhibition of Smad7 With a Specific Antisense Oligonucleotide Facilitates TGF-β1-Mediated Suppression of Colitis 377
IL-21 regulates experimental colitis by modulating the balance between T-reg and Th17 cells 376
IL-21 in the pathogenesis and treatment of skin diseases 375
Investigational cytokine-targeted therapies for ulcerative colitis 375
Preclinical studies of a specific PPARγ modulator in the control of skin inflammation 375
CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease 374
Totale 40.332
Categoria #
all - tutte 148.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.103


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194.378 0 0 0 0 0 0 0 0 0 0 2.248 2.130
2019/202022.282 1.836 1.729 1.605 1.962 1.751 2.514 2.030 2.032 2.053 1.844 1.355 1.571
2020/202113.467 1.228 1.609 1.801 1.696 1.295 1.467 1.631 1.317 306 447 472 198
2021/20222.857 138 233 122 158 82 230 119 108 364 293 222 788
2022/20233.445 342 305 69 441 327 794 289 218 323 63 188 86
2023/20241.001 149 39 88 27 126 237 69 229 16 19 2 0
Totale 80.673